Literature DB >> 30915504

Targeting ideal oral vaccine vectors based on probiotics: a systematical view.

Boyu Jiang1,2, Zhendong Li1,2, Bingming Ou1,2,3, Qiangde Duan4,5, Guoqiang Zhu6,7.   

Abstract

Probiotics have great potential to be engineered into oral vaccine delivery systems, which can facilitate elicitation of mucosal immunity without latent risks of pathogenicity. Combined with the progressive understanding of probiotics and the mucosal immune system as well as the advanced biotechniques of genetic engineering, the development of promising oral vaccine vectors based on probiotics is available while complicated and demanding. Therefore, a systematical view on the design of practical probiotic vectors is necessary, which will help to logically analyze and resolve the problems that might be neglected during our exploration. Here, we attempt to systematically summarize several fundamental issues vital to the effectiveness of the vector of probiotics, including the stability of the engineered vectors, the optimization of antigen expression, the improvement of colonization, and the enhancement of immunoreactivity. We also compared the existent strategies and some developing ones, attempting to figure out an optimal strategy that might deserve to be referred in the future development of oral vaccine vectors based on probiotics.

Keywords:  Colonization; Immunoreactivity; Oral vaccine vector; Probiotics; Stability

Mesh:

Substances:

Year:  2019        PMID: 30915504     DOI: 10.1007/s00253-019-09770-7

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  7 in total

1.  Bacillus subtilis Expressing the Infectious Pancreatic Necrosis Virus VP2 Protein Retains Its Immunostimulatory Properties and Induces a Specific Antibody Response.

Authors:  Félix Docando; Noelia Nuñez-Ortiz; Gabriela Gonçalves; Cláudia R Serra; Eduardo Gomez-Casado; Diana Martín; Beatriz Abós; Aires Oliva-Teles; Carolina Tafalla; Patricia Díaz-Rosales
Journal:  Front Immunol       Date:  2022-06-01       Impact factor: 8.786

Review 2.  Inflammatory Bowel Disease Therapeutics: A Focus on Probiotic Engineering.

Authors:  Jayshree Mishra; Madyson Stubbs; Longxiang Kuang; Nitza Vara; Priyam Kumar; Narendra Kumar
Journal:  Mediators Inflamm       Date:  2022-01-17       Impact factor: 4.711

Review 3.  Probiotics as multifaceted oral vaccines against colon cancer: A review.

Authors:  Shubhi Singh; Manisha Singh; Smriti Gaur
Journal:  Front Immunol       Date:  2022-10-03       Impact factor: 8.786

Review 4.  Adjuvant Strategies for Lactic Acid Bacterial Mucosal Vaccines.

Authors:  Allison C Vilander; Gregg A Dean
Journal:  Vaccines (Basel)       Date:  2019-10-16

Review 5.  A cross talk between the immunization and edible vaccine: Current challenges and future prospects.

Authors:  Ankit Sahoo; Ashok Kumar Mandal; Khusbu Dwivedi; Vikas Kumar
Journal:  Life Sci       Date:  2020-08-26       Impact factor: 5.037

Review 6.  Could Probiotics and Postbiotics Function as "Silver Bullet" in the Post-COVID-19 Era?

Authors:  Svetoslav Dimitrov Todorov; John Robert Tagg; Iskra Vitanova Ivanova
Journal:  Probiotics Antimicrob Proteins       Date:  2021-08-13       Impact factor: 4.609

Review 7.  Using crystallography tools to improve vaccine formulations.

Authors:  Márcia Carvalho de Abreu Fantini; Cristiano Luis Pinto Oliveira; José Luiz de Souza Lopes; Tereza da Silva Martins; Milena Apetito Akamatsu; Aryene Góes Trezena; Milene Tino-De- Franco; Viviane Fongaro Botosso; Osvaldo Augusto Brazil Esteves Sant'Anna; Nikolay Kardjilov; Martin Kjaerulf Rasmussen; Heloísa Nunes Bordallo
Journal:  IUCrJ       Date:  2021-11-25       Impact factor: 4.769

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.